AARD Earnings & Financial Statements
Aardvark Therapeutics, Inc. Common Stock
$3.88
-$0.16(-3.96%)
29
Overall
60
Value
10
Tech
18
Quality
Market Cap
$84.91M
Volume
126.57K
52W Range
$3.35 - $16.60
Target Price
$11.11
AARD earnings and financial statements: Aardvark Therapeutics, Inc. Common Stock's income statement, balance sheet and cash flow statement, annual and quarterly.
AARD Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating income | -$62.73M | -$22.79M | -$7.42M | -$9.9K |
| EBITDA | -$57.55M | - | - | -$13.5K |
| Net income | -$57.59M | -$20.59M | -$7.21M | -$13.6K |
| EPS (diluted) | $-2.93 | $-5.15 | $-1.82 | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Total assets | $117.18M | $77.51M | $10.54M | $16.8K |
| Total liabilities | $10.55M | $5.39M | $1.43M | $776.00 |
| Shareholders’ equity | $106.63M | $72.11M | $9.10M | $16.0K |
| Cash and equivalents | $47.05M | $61.64M | $9.73M | $15.6K |
| Long-term debt | - | $441.0K | $50.0K | - |
| Fiscal year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating cash flow | -$54.17M | -$18.09M | -$5.82M | $16.6K |
| Capital expenditure | -$95.0K | - | - | - |
| Free cash flow | -$54.27M | -$18.20M | -$5.82M | $16.6K |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AARD | $3.88 | -4.0% | 126.57K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Aardvark Therapeutics, Inc. Common Stock Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW